Inna Kuperstein - Institut Curie | 人才画像

基本信息

Career Trajectory

Bio

Researcher at Institut Curie, Paris France in the field of systems biology of cancer and other human diseases. Construction of comprehensive cell signalling maps; development of tools for navigation big molecular map; integration, visualisation, analysis and interpretation of high-throughput data in the context of comprehensive cell signalling maps. Modelling synthetic interactions between genes implicated in cancer and other human diseases for predicting drug response and resistance mechanisms.

Research Interests

Papers共 76 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Drug-target Identification in COVID-19 Disease Mechanisms Using Computational Systems Biology Approaches

Anna Niarakis,Marek Ostaszewski,Alexander Mazein,Inna Kuperstein,Martina Kutmon,Marc E. Gillespie,Akira Funahashi,Marcio Luis Acencio,Ahmed Hemedan,Michael Aichem,Karsten Klein,Tobias Czauderna,Felicia Burtscher,Takahiro G. Yamada,Yusuke Hiki,Noriko F. Hiroi,Finterly Hu,Nhung Pham,Friederike Ehrhart,Egon L. Willighagen,Alberto Valdeolivas,Aurelien Dugourd,Francesco Messina,Marina Esteban-Medina,Maria Pena-Chilet,Kinza Rian,Sylvain Soliman,Sara Sadat Aghamiri,Bhanwar Lal Puniya,Aurelien Naldi,Tomas Helikar,Vidisha Singh, Marco Farinas Fernandez, Viviam Bermudez,Eirini Tsirvouli,Arnau Montagud,Vincent Noel,Miguel Ponce-de-Leon,Dieter Maier,Angela Bauch,Benjamin M. Gyori,John A. Bachman,Augustin Luna,Janet Pinero,Laura I. Furlong,Irina Balaur,Adrien Rougny,Yohan Jarosz,Rupert W. Overall,Robert Phair,Livia Perfetto,Lisa Matthews,Devasahayam Arokia Balaya Rex,Marija Orlic-Milacic,Luis Cristobal Monraz Gomez,Bertrand De Meulder,Jean Marie Ravel,Bijay Jassal,Venkata Satagopam,Guanming Wu,Martin Golebiewski,Piotr Gawron,Laurence Calzone,Jacques S. Beckmann,Chris T. Evelo,Peter D'Eustachio,Falk Schreiber,Julio Saez-Rodriguez,Joaquin Dopazo,Martin Kuiper,Alfonso Valencia,Olaf Wolkenhauer,Hiroaki Kitano,Emmanuel Barillot,Charles Auffray,Rudi Balling,Reinhard Schneider

FRONTIERS IN IMMUNOLOGY (2024)

Cited0Views0WOSBibtex

Supplementary figure S4 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors

Wael Jdey,Sylvain Thierry,Christophe Russo,Flavien Devun,Muthana Al Abo,Patricia Noguiez-Hellin,Jian-Sheng Sun,Emmanuel Barillot,Andrei Zinovyev,Inna Kuperstein,Yves Pommier, Marie Dutreix

crossref（2023）

Cited0Views0Bibtex

Supplementary table 2 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors

Wael Jdey,Sylvain Thierry,Christophe Russo,Flavien Devun,Muthana Al Abo,Patricia Noguiez-Hellin,Jian-Sheng Sun,Emmanuel Barillot,Andrei Zinovyev,Inna Kuperstein,Yves Pommier, Marie Dutreix

crossref（2023）

Cited0Views0Bibtex

Supplementary figure S3 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors

Wael Jdey,Sylvain Thierry,Christophe Russo,Flavien Devun,Muthana Al Abo,Patricia Noguiez-Hellin,Jian-Sheng Sun,Emmanuel Barillot,Andrei Zinovyev,Inna Kuperstein,Yves Pommier, Marie Dutreix

crossref（2023）

Cited0Views0Bibtex

Supplementary table 3 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors

Wael Jdey,Sylvain Thierry,Christophe Russo,Flavien Devun,Muthana Al Abo,Patricia Noguiez-Hellin,Jian-Sheng Sun,Emmanuel Barillot,Andrei Zinovyev,Inna Kuperstein,Yves Pommier,Marie Dutreix

crossref（2023）

Cited0Views0Bibtex

Supplementary table 1 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors

Wael Jdey,Sylvain Thierry,Christophe Russo,Flavien Devun,Muthana Al Abo,Patricia Noguiez-Hellin,Jian-Sheng Sun,Emmanuel Barillot,Andrei Zinovyev,Inna Kuperstein,Yves Pommier, Marie Dutreix

crossref（2023）

Cited0Views0Bibtex

Supplementary figure S4 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors

Wael Jdey,Sylvain Thierry,Christophe Russo,Flavien Devun,Muthana Al Abo,Patricia Noguiez-Hellin,Jian-Sheng Sun,Emmanuel Barillot,Andrei Zinovyev,Inna Kuperstein,Yves Pommier, Marie Dutreix

crossref（2023）

Cited0Views0Bibtex

Supplementary figure S3 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors

Wael Jdey,Sylvain Thierry,Christophe Russo,Flavien Devun,Muthana Al Abo,Patricia Noguiez-Hellin,Jian-Sheng Sun,Emmanuel Barillot,Andrei Zinovyev,Inna Kuperstein,Yves Pommier, Marie Dutreix

crossref（2023）

Cited0Views0Bibtex

Supplementary table 4 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors

Wael Jdey,Sylvain Thierry,Christophe Russo,Flavien Devun,Muthana Al Abo,Patricia Noguiez-Hellin,Jian-Sheng Sun,Emmanuel Barillot,Andrei Zinovyev,Inna Kuperstein,Yves Pommier, Marie Dutreix

crossref（2023）

Cited0Views0Bibtex

Supplementary table 3 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors

Wael Jdey,Sylvain Thierry,Christophe Russo,Flavien Devun,Muthana Al Abo,Patricia Noguiez-Hellin,Jian-Sheng Sun,Emmanuel Barillot,Andrei Zinovyev,Inna Kuperstein,Yves Pommier,Marie Dutreix

crossref（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn